# Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain
Canonical URL: https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-announces-first-participant-dosed-in-phase-1-investigator-initiated-pharmacodynamic-study-of-tnx-1900-intranasal-potentiated-oxytocin-to-assess-potential-for-treating-migraine-and-craniofacial-pain
Ticker: TNXP
Company: Tonix Pharmaceuticals
Source: Tonix Pharmaceuticals
Published: 2026-03-26 11:00 EST
Original Source URL: https://ir.tonixpharma.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-27 11:00 EST — [Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-to-report-second-quarter-2026-financial-results-on-august--7e18d9ce) — Source: Tonix Pharmaceuticals
- 2026-07-15 13:05 EST — [Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models](https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-announces-publication-in-the-peer-reviewed-journal-of-viro-14c8c277) — Source: Tonix Pharmaceuticals
- 2026-07-13 11:00 EST — [Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA®](https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-announces-major-managed-medicare-payer-agreement-for-tonmy-bb25eccc) — Source: Tonix Pharmaceuticals
- 2026-06-29 11:25 EST — [Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)](https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-announces-first-patient-enrolled-in-phase-2-horizon-study--041b721f) — Source: Tonix Pharmaceuticals
- 2026-06-11 11:00 EST — [Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026](https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-to-attend-btig-infectious-disease-day-2026-f9bab1aa) — Source: Tonix Pharmaceuticals
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)